Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion

Affiliations

¹ Interinstitutional Epidemiology Unit, Azienda Unita Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy, Arcispedale S. Maria Nuova, National Institute for Research and Treatment, Reggio Emilia, Italy.
² Center for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy.
³ Karolinska Institute, Stockholm, Sweden.
⁴ Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
⁵ Belgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium.
⁶ S. C. Laboratory for the Prevention of Cancer, Institute for the Study and Prevention of Cancer, Florence, Italy.
⁷ Veneto Institute of Oncology, National Institute for Research and Treatment, Padua, Italy.
⁸ Cancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
⁹ Department of Obstetrics and Gynecology, Wolfsburg Hospital, Wolfsburg, Germany.
¹⁰ Institute of Microbiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
¹¹ Regione Emilia-Romagna, Bologna, Italy.

Free article

Comment

Paolo Giorgi Rossi et al. Cancer Cytopathol. 2016 Jan.

Free article

. 2016 Jan;124(1):66-7.

doi: 10.1002/cncy.21622. Epub 2015 Sep 10.

¹ Interinstitutional Epidemiology Unit, Azienda Unita Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy, Arcispedale S. Maria Nuova, National Institute for Research and Treatment, Reggio Emilia, Italy.
² Center for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy.
³ Karolinska Institute, Stockholm, Sweden.
⁴ Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
⁵ Belgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium.
⁶ S. C. Laboratory for the Prevention of Cancer, Institute for the Study and Prevention of Cancer, Florence, Italy.
⁷ Veneto Institute of Oncology, National Institute for Research and Treatment, Padua, Italy.
⁸ Cancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
⁹ Department of Obstetrics and Gynecology, Wolfsburg Hospital, Wolfsburg, Germany.
¹⁰ Institute of Microbiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
¹¹ Regione Emilia-Romagna, Bologna, Italy.

No abstract available

Comment in

Reply to why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.
Rabin DS. Rabin DS. Cancer Cytopathol. 2016 Jan;124(1):68-9. doi: 10.1002/cncy.21621. Epub 2015 Sep 10. Cancer Cytopathol. 2016. PMID: 26356028 No abstract available.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Blatt AJ, et al. Cancer Cytopathol. 2015 May;123(5):282-8. doi: 10.1002/cncy.21544. Epub 2015 Apr 10. Cancer Cytopathol. 2015. PMID: 25864682 Free PMC article.